Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades T2 Biosystems to Neutral

BTIG Downgrades T2 Biosystems to Neutral

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

July 7, 2022

1 minute read

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Stifel Maintains Buy on IBM, Lowers Price Target to $140

October 17, 7:08 AM

Stifel analyst David Grossman maintains IBM (NYSE:IBM) with a Buy and lowers the price target from $150 to $140.

October 7, 5:03 PM

Elon Musk's acquisition of Twitter, now known as X, has led to unforeseen financial challenges.

April 20, 1:01 PM

Within the last quarter, Elevance Health (NYSE:ELV) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

April 20, 4:00 PM

Over the past 3 months, 6 analysts have published their opinion on Genmab (NASDAQ:GMAB) stock. These analysts are…